News About: Med. Insurance
Hanmi’s Pidogle to benefit from health insurance
The National Health Insurance Corporation says Hamnmi Pharm’s Pidogle, a chemically modified clopidogrel, will be eligible for health insurance from next month.
“We have amicably reached an agreement with Hanmi to ...
Insurance price troubles Daewoong
Daewoong Pharm, which had been negotiating with the National Health Insurance Corporation over insurance price of Vixgrel tablet, a chemically modified clopidogrel preparation, is now faced with tough challenges.
A...
Positive list system corners pharmaceutical firms
Foreign and domestic pharmaceutical manufacturers are worrying about the current drug pricing system, the so-called positive list system, to allow only cost-effective drugs to be covered by national health insurance.
...
205 items to benefit from health insurance
The Ministry of Health, Welfare and Family Affairs has announced that 205 medicines will be eligible for health insurance from June 1.
Included in the 205 items are BMS Korea’s Sprycel and Chong Kun Dang’s Prigrel....
Plaxvix sales still pick up steam
Last year’s sales of anticlotting drug Plavix topped the list in the domestic prescription market with 117.1 billion won, according to EDI (electronic data interchange) data released by the Health Insurance Review Age...
Korean generic medicines deemed expensive
The Korea Development Institute (KDI) said on May 22 Korean generic medicines that require health insurance coverage are 4 times higher than those in seven other countries, including the United States.
The KDI also...
Reclassification plan will not affect pharmacy sales
The government is considering expanding the scope of quasi-drugs to digestives and preparations for intestinal flora, but its reclassification plan will not hit pharmacy sales, according to the Ministry of Health, Wel...
Price determination of new leukemia drug to be delayed
The Ministry for Health, Welfare and Family Affair committee's decision on the price of Sprycel, a new drug for the disease, will be delayed, following its April 28 meeting.
The National Health Insurance Corp. sugg...
Health insurance price of chemically modified Plavix to be determined
The Health Insurance Review Agency is now under negotiation to determine the insurance price of Daewoong’s Vixgrel, one of chemically modified Plavix (clopidogrel bisulfate), which have drawn keen interest from other ...
Restricted reimbursement of Crestor, Rivaro to be withheld
The Health Insurance Review Agency will reassess the health insurance coverage of Crestor (rosuvastatin) and Rivaro (pitavastatin), while the prices of other stastins are likely to be reduced.
The agency is also in...
